ArticleFrontiers in nutrition2026
Impact of diets high in trans-fatty acids on cardiovascular diseases in adults aged 55 and older: insights from the Global Burden of Disease 2021 data.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High trans-fatty acid (TFA) intake is a major modifiable risk factor for cardiovascular disease (CVD), especially in older adults. This study aimed to assess global trends and health inequalities in CVD burden attributable to high TFA intake from 1990 to 2021 and project future patterns through 2036. Methods: Using data from the Global Burden of Disease (GBD) Study 2021, we analyzed age-standardized mortality rates (ASMR), disability-adjusted life years (ASDR), and inequality indicators across 204 countries and territories. Age-Period-Cohort (APC) models and Bayesian projections were applied to estimate future trends. Results: Globally, ASMR and ASDR attributable to high TFA intake declined by 69 and 68%, respectively, from 1990 to 2021. The most significant reductions were observed in high-SDI regions, where comprehensive TFA bans and public health policies were implemented. In contrast, the absolute burden remains high in low- and middle-SDI countries due to limited policy enforcement and dietary interventions. Socioeconomic inequalities narrowed over time, but vulnerable populations still face elevated risks. Projections indicate a continued global decline in CVD burden attributable to TFA through 2036, though widening uncertainties reflect demographic and policy challenges. Conclusion: While global progress in reducing TFA-related CVD burden is evident, persistent disparities and emerging risks in low-resource settings underscore the need for global elimination of industrial TFA, strengthened health systems, and targeted strategies to protect high-risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.